• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JTH2400057 10-羟基吗啡 Active ingredient Chemical Drugs Disposable Import Drug Application 2024-04-17 view
JXSB2400037 Amlitelimab注射液 amlitelimab Injection Biological Products(1) Supplementary Application 2024-04-17 view
JXSL2400076 Amlitelimab注射液 amlitelimab Injection Biological Products(1) Import Drug Application 2024-04-17 view
JXSB2400038 Amlitelimab注射液 amlitelimab Injection Biological Products(1) Supplementary Application 2024-04-17 view
JXSL2400078 Anifrolumab注射液 anifrolumab Injection Biological Products(2.2) Import Drug Application 2024-04-20 view
CXHB2400102 AP301胶囊 AP-301 Capsule Chemical Drugs(1) Supplementary Application 2024-04-24 view
CXHB2400101 AP301胶囊 AP-301 Capsule Chemical Drugs(1) Supplementary Application 2024-04-24 view
JXSL2400077 Axatilimab注射液 axatilimab Injection Biological Products(1) Import Drug Application 2024-04-19 view
CXSL2400255 BC008-1A注射液 (1) 2024-04-23 view
CXSL2400255 BC008-1A注射液 BC008-1A Injection Biological Products(1) New Drug Application 2024-04-23 Sichuan Luzhou Bubu Biopharmaceutical Co Ltd view
CXHL2400382 BCM894胶囊 BCM-894 Capsule Chemical Drugs(2.3) New Drug Application 2024-04-17 Shanghai Bo Zhiyan New Drug Technology Co Ltd view
CXHL2400383 BR170720口服混悬液 BR-170720 Suspension Chemical Drugs(2.2) New Drug Application 2024-04-17 Shandong Bestcomm Pharmaceutical Company Limited view
JXSB2400041 Brolucizumab注射液 brolucizumab Injection Biological Products(2.2) Supplementary Application 2024-04-19 view
JXSB2400040 Brolucizumab注射液 brolucizumab Injection Biological Products(3.1) Supplementary Application 2024-04-19 view
JXSB2400042 DS-1062a (1) 2024-04-22 view
JXSB2400042 DS-1062a datopotamab deruxtecan Injection Biological Products(1) Supplementary Application 2024-04-22 view
JXSB2400043 DS-6000a raludotatug deruxtecan Injection Biological Products(1) Supplementary Application 2024-04-23 view
JXSB2400043 DS-6000a (1) 2024-04-23 view
JXSL2400080 Efgartigimod注射液 Biological Products(2.2) Import Drug Application 2024-04-24 view
CXHB2400096 EG017软膏 EG017 Ointment Chemical Drugs(1) Supplementary Application 2024-04-17 Changchun GeneScience Pharmaceutical Co Ltd view